在LMIC中为死产预防和死产后丧亲护理设置了一个元核心结果
Kushupika Dube1, Farai Marenga2, Elizabeth Ombeva Ayebare3
1Mpilo School of Midwifery, Mpilo Central Hospital, Bulawayo, Zimbabwe.
BMJ global health
|January 28, 2025
概括
这项研究建立了关于低收入国家预防死产和丧亲关怀的核心结果的共识. 这些结果将提高研究的一致性,并支持全球死产研究工作.
科学领域:
- 全球健康 全球健康
- 产科和妇科 产科和妇科
- 围产儿医学 围产儿医学
背景情况:
- 在低收入和中等收入国家 (LMICs),特别是撒哈拉以南非洲和南亚,死产造成了重大负担.
- 现有的预防死产和丧亲护理的核心结果集 (COS) 是在LMIC人口的有限投入下开发的.
- 在当前的死产结果指标中,存在一个缺口,反映了LMIC中父母和医疗保健系统的特定需求.
研究的目的:
- 在撒哈拉以南非洲和南亚地区,就预防死产的最重要的结果达成共识.
- 建立关于在撒哈拉以南非洲和南亚死产后丧亲护理最重要的结果的共识.
- 为弥补LMIC特定对死产结果测量需求的差距.
主要方法:
- 研究领导人和来自六个撒哈拉以南非洲和两个南亚国家的社区成员对以前的死产结果进行了审查.
- 在线Delphi调查对医疗保健专业人员,经历死产的父母和研究人员进行了调查,以得分结果的相关性.
- 召开了一个虚拟共识会议,讨论Delphi结果并最终确定核心成果集 (COS).
主要成果:
- 在五个领域预防死产的13个核心结果上达成共识:产科,胎儿,围产,新生儿和孕产妇并发症.
- 关于丧亲护理的五个核心结果得到了一致同意,包括分娩和分娩,分娩后并发症,护理经验,心理健康和情绪/社会福祉.
- 德尔菲调查涉及287名参与者,包括助产士,产科医生,母亲,父亲和研究人员,在协商一致会议上有家长代表.
结论:
- 开发的COS将提高未来在LMIC环境中进行的死产研究结果的一致性.
- 这些COS将补充高收入国家开发的现有死产结果集.
- 这项工作有助于为全球死产研究开发一套全球结果.
相关概念视频
Study Designs in Epidemiology
173
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
173
Standards of Care II
635
Nurses bear specific legal responsibilities under several federal statutes, including:
635
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Cancer Survival Analysis
324
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
324
Standards of Care I
668
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
668
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K


